Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2026)

Elanco Animal Health has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $13.2 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 2.17% year-over-year to $13.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.9 billion (up 2.42% YoY) and the FY2025 annual result came in at $13.4 billion, up 5.9% from the prior year.
• Liabilities and Shareholders Equity retreated to $13.2 billion in Q1 2026 per ELAN's latest filing, from $13.4 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $16.3 billion in Q1 2022 and troughed at $12.6 billion in Q4 2024.
• A 5-year average of $14.3 billion and a median of $14.0 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity retreated 12.86% in 2024, then grew 5.9% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $15.5 billion in 2022, then dropped by 7.29% to $14.4 billion in 2023, then retreated by 12.17% to $12.6 billion in 2024, then climbed by 5.9% to $13.4 billion in 2025, then fell by 1.02% to $13.2 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $13.2 billion, $13.4 billion, and $13.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.